Ads
related to: drug identifier
Search results
JD Supra: New Jersey Regulatory Update Part I
JD Supra· 8 hours agoThe amendments add requirements for PACT service providers, including, among others, having a valid National Provider Identifier, having a taxonomy code, and remaining in ...
What is data de-identification? | Definition from TechTarget
SearchSecurity.com· 3 days agoThis allows organizations to use and share data while minimizing the risks related to business governance, regulatory compliance and potential PII data breaches or misuse. Organizations looking ...
U.S. Clinical Trials Begin for Twice-Yearly HIV Prevention Injection, NIH Reports
Sierra Sun Times· 1 day agoThe mid-stage studies will assess the safety, acceptability, and pharmacokinetics (how a drug moves...
Pharma Ad Startup Snags Seed Funding To Support Better TV Ad Targeting | AdExchanger
AdExchanger· 2 days agoPharma brands spend billions of dollars every year on poorly targeted TV advertising. A new startup...
Provider Impacts from Recent Health Care Cyberattacks
Reuters· 7 days agoChange Healthcare is a claims processing network that is part of Optum, a subsidiary of UnitedHealth Group. On February 21, 2024, Change Healthcare experienced a cyberattack that forced the ...
UK Proposes Approving Medical Devices Based on Approval in Other Countries | JD Supra
JD Supra· 3 days agoDevice manufacturers may soon have access to a new framework for marketing and selling medical devices in the United Kingdom. On May 21, 2024, the UK Medicines and Healthcare products Regulatory ...
How private is abortion data for patients who leave Idaho? Experts raise concerns
The Idaho Statesman· 2 days agoHow private is abortion data for patients who leave Idaho? “It was supposed to be anonymous, but they asked for patient identifiers on it, so I was like, ‘Could this get tracked back to them?’” she said.
Ala. man arrested for 'doxing' LEO by falsely accusing him of being involved in a deadly crash
Police1· 3 days agoA Eufaula man is under arrest after authorities say he falsely accused a police officer of being...
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological...
Benzinga· 1 day agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin
TuHURA Biosciences and Kintara Therapeutics Announce Positive Results from Phase 1b Trial of...
The Joplin Globe· 5 days agoTAMPA, FL and SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / TuHURA Biosciences, Inc. ("TuHURA"), a Phase 3 registration-stage immune-oncology company developing novel technologies to overcome ...
